These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3973065)

  • 1. Studies with stable isotopes III: Pharmacokinetics of tracer doses of drug.
    Browne TR; Greenblatt DJ; Harmatz JS; Evans JE; Szabo GK; Evans BA; Schumacher GE
    J Clin Pharmacol; 1985; 25(1):59-63. PubMed ID: 3973065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with stable isotopes I: Changes in phenytoin pharmacokinetics and biotransformation during monotherapy.
    Browne TR; Evans JE; Szabo GK; Evans BA; Greenblatt DJ; Schumacher GE
    J Clin Pharmacol; 1985; 25(1):43-50. PubMed ID: 3973063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with stable isotopes II: Phenobarbital pharmacokinetics during monotherapy.
    Browne TR; Evans JE; Szabo GK; Evans BA; Greenblatt DJ
    J Clin Pharmacol; 1985; 25(1):51-8. PubMed ID: 3973064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between phenobarbital and thioridazine.
    Gay PE; Madsen JA
    Neurology; 1983 Dec; 33(12):1631-2. PubMed ID: 6685838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability studies of drugs with nonlinear pharmacokinetics: II. Absolute bioavailability of intravenous phenytoin prodrug at therapeutic phenytoin serum concentrations determined by double-stable isotope technique.
    Browne TR; Szabo GK; McEntegart C; Evans JE; Evans BA; Miceli JJ; Quon C; Dougherty CL; Kres J; Davoudi H
    J Clin Pharmacol; 1993 Jan; 33(1):89-94. PubMed ID: 8429121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics: dose-dependent changes.
    Browne TR; Greenblatt DJ; Evans JE; Szabo GK; Evans BA; Schumacher GE
    J Clin Pharmacol; 1986; 26(6):463-8. PubMed ID: 3734138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics.
    Browne TR; Szabo GK; Evans J; Evans BA; Greenblatt DJ; Mikati MA
    Neurology; 1988 Apr; 38(4):639-42. PubMed ID: 3352926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic equivalence of stable-isotope-labeled and unlabeled phenytoin.
    Browne TR; Van Langenhove A; Costello CE; Biemann K; Greenblatt DJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):511-5. PubMed ID: 7471618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of phenytoin and phenobarbital in capillary blood by Ames Seralyzer.
    Graves NM; Holmes GB; Leppik IE; Galligher TK; Parker DR
    Epilepsia; 1987; 28(6):713-6. PubMed ID: 3691418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interactions of mesuximide with phenobarbital and phenytoin in hospitalized epileptic patients.
    Rambeck B
    Epilepsia; 1979 Apr; 20(2):147-56. PubMed ID: 110583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of phenobarbital and phenytoin in pregnant rats and their fetuses.
    DeVane CL; Simpkins JW; Stout SA
    Epilepsia; 1991; 32(2):250-6. PubMed ID: 2004629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva.
    Dwivedi R; Singh M; Kaleekal T; Gupta YK; Tripathi M
    Int J Neurosci; 2016 Nov; 126(11):972-8. PubMed ID: 26441313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of chloramphenicol with phenytoin and phenobarbital. Case report.
    Koup JR; Gibaldi M; McNamara P; Hilligoss DM; Colburn WA; Bruck E
    Clin Pharmacol Ther; 1978 Nov; 24(5):571-5. PubMed ID: 699481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on cerebrospinal fluid and saliva to serum concentration ratios of anticonvulsants--Phenytoin, Phenobarbital, Valproic Acid and Primidone in epileptic patients].
    Kido H
    Seishin Shinkeigaku Zasshi; 1982; 84(9):661-79. PubMed ID: 6820506
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic equivalence of stable-isotope-labeled and unlabeled drugs. Phenobarbital in man.
    Browne TR; Van Langenhove A; Costello CE; Biemann K; Greenblatt DJ
    J Clin Pharmacol; 1982 Jul; 22(7):309-15. PubMed ID: 7107979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin and phenobarbital stable isotope studies in neonates.
    Malik SI; Painter MJ; Venkataramanan R; Alvin JD
    Pediatr Neurol; 2003 Nov; 29(5):376-80. PubMed ID: 14684232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin pharmacokinetics: before and after folic acid administration.
    Berg MJ; Fincham RW; Ebert BE; Schottelius DD
    Epilepsia; 1992; 33(4):712-20. PubMed ID: 1628589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined phenytoin and phenobarbital overdose.
    Vlasses PH; Rocci ML; Koffer H; Ferguson RK
    Drug Intell Clin Pharm; 1982 Jun; 16(6):487-8. PubMed ID: 7094844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical and theoretical aspects of phenytoin administration. I. Relationship between dose and plasma concentration.
    Driessen O; Höppener RJ; van der Velde EA
    Eur Neurol; 1980; 19(6):353-65. PubMed ID: 7439208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.